CrowdStrike has staged one of its most dramatic reversals in recent memory — the stock closed August at $231, up 21% on the week and 23% on the day after earnings, a complete inversion of the cautious setup described in last week's notes.
The earnings reaction changes the short interest story materially. Short interest has now fallen to 9.46% of the free float — 23.7 million shares — down nearly 9% on the week and 12% over the past month. That continues the retreat from the mid-July peak above 28 million shares flagged in prior notes, and the post-earnings price surge accelerates the pressure on remaining bears. With availability effectively unconstrained — over a billion shares available to borrow and cost to borrow running at just 0.33% — there is no mechanical squeeze at play. The shorts still in the trade are carrying an open loss on a 21% weekly move and are sitting in a lending market that imposes no friction to either side. Options positioning has normalised sharply: the put/call ratio has dropped to 0.95, back below its 20-day average of 0.96 and well within one standard deviation. The defensive hedging that characterised the pre-earnings setup has unwound almost entirely.
The analyst community moved fast after the print. Over a dozen firms raised targets in the two days following results, and the direction was uniformly positive — not a single downgrade in the batch. Truist lifted its target to $300 from $245 on September 1. Citigroup moved to $260 from $250. Piper Sandler raised to $240 from $188. BMO Capital raised to $235 from $186. Even the more cautious names nudged higher: Baird, which holds a Neutral, lifted its target to $230. With the stock now trading at $231, consensus has been effectively caught by the price — the mean analyst target is $230.32, virtually flat with the close. The bulls still have an upside case, with some targets stretching to $300 and above, but the easy re-rating trade from a beaten-down entry has largely run. Valuation reflects the re-rate: the trailing P/E now runs at 148x and EV/EBITDA near 105x, both up meaningfully over the past 30 days. The forward EPS momentum score ranks in the 95th percentile on a 12-month basis, underpinning the bull case on growth. Bears point to AI monetisation uncertainty and pressure from Microsoft and other platform players — the bear case in the Benzinga model flags high valuation as the primary structural risk.
The institutional ownership picture shows broad engagement with no activist angle. BlackRock holds 8.5% and added 1.9 million shares in the most recent reported period. FMR (Fidelity) added 16.9 million shares, and JP Morgan Asset Management added 14.2 million — both significant moves. The activist register carries only passive 13G filings, with no 13D holders on record. Insider activity remains routine: CEO George Kurtz filed multiple small sales on August 28, totalling around $1.6 million in aggregate, all executed under a pre-arranged 10b5-1 plan. Plan-driven sales carry limited informational weight, and the volumes involved are modest relative to the stock's daily turnover.
Among close peers, PANW rose 8.9% on the week and FTNT gained 12.5% — both strong, but both lagging CRWD's 21% move. RBRK was the outlier, down 5.1% on the week, suggesting the post-earnings lift was CRWD-specific rather than a broad cybersecurity re-rating. The ORTEX short score has declined steadily from 35.9 in mid-August to 33.2 now, consistent with shorts unwinding and bearish pressure easing.
The next scheduled earnings event is November 24. Between now and then, the key variable is whether the Street's targets — many of which are now at or below the current price — get revised upward again, or whether the stock consolidates while consensus catches up.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
